Trastuzumab
MYL-Her 3001
Phase 3 mab completed
Quick answer
Trastuzumab for Breast Cancer is a Phase 3 program (mab) at Mylan IRE Healthcare Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mylan IRE Healthcare Limited
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed